Effect of Bu Zhong Yi Qi Tang on Myasthenia Gravis
Efficacy of Meridian Energy and Heart Rate Variability in Patients with Ocular Myasthenia Gravis by Using Chinese and Western Medicine Treatment
This study tests if a traditional Chinese medicine called Bu Zhong Yi Qi Tang can help people with ocular myasthenia gravis feel better when used alongside their regular treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 112 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | National Taipei University of Nursing and Health Sciences Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Taipei) |
| Trial ID | NCT06881173 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of Bu Zhong Yi Qi Tang, a traditional Chinese medicine, in combination with Western medicine for patients diagnosed with ocular myasthenia gravis. The approach focuses on enhancing meridian energy and autonomic nervous system function to alleviate symptoms associated with the condition. Participants will receive either the herbal treatment or a placebo while continuing their prescribed medication. The study aims to provide insights into integrated treatment methods for myasthenia gravis.
Who should consider this trial
Good fit: Ideal candidates are adults over 20 years old diagnosed with ocular myasthenia gravis who can communicate in Mandarin or Taiwanese.
Not a fit: Patients with severe liver or kidney failure, malignant tumors, or those currently undergoing chemotherapy or radiotherapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could improve the quality of life and symptom management for patients with myasthenia gravis.
How similar studies have performed: While the integration of traditional Chinese and Western medicine is a novel approach, similar studies have shown promising results in other conditions, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with ocular myasthenia by a doctor * Western medicine prescriptions only take oral Mestinon (Pyrido stigmine Bromide) * Patients over 20 years old * Can understand and understand Those who can speak Mandarin or Taiwanese * those with a clear state of consciousness and no diagnosis of mental illness * patients and their families who are willing to receive precise integrated treatment of traditional Chinese and Western medicine. Exclusion Criteria: * Patients with liver failure or kidney failure * Allergy symptoms to traditional Chinese medicine, such as skin itching and redness * Patients with malignant tumors * Patients currently undergoing radiotherapy and chemotherapy * Pregnant * Cardiac rhythm device implementer
Where this trial is running
Taipei
- Shin Kong Wu Ho-Su Memorial Hospital — Taipei, Taiwan (Recruiting)
Study contacts
- Study coordinator: yuting Cheng
- Email: tyghaw3261635@gmail.com
- Phone: +8860988773890
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.